
Sign up to save your podcasts
Or
Chad Robins, CEO and Co-founder of Adaptive Biotechnologies, discusses their recent partnership with Microsoft to decode the immune system's response to CODVID-19 and develop better diagnostic tools and their partnership with Amgen to develop potential antibody therapies to treat the disease. Chad also shares how the medical field is adapting and facing new challenges during this pandemic.
See omnystudio.com/listener for privacy information.
4.9
7777 ratings
Chad Robins, CEO and Co-founder of Adaptive Biotechnologies, discusses their recent partnership with Microsoft to decode the immune system's response to CODVID-19 and develop better diagnostic tools and their partnership with Amgen to develop potential antibody therapies to treat the disease. Chad also shares how the medical field is adapting and facing new challenges during this pandemic.
See omnystudio.com/listener for privacy information.
77,550 Listeners
2,183 Listeners
9,120 Listeners
57,901 Listeners